<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(9)</volume><submitter>Yau YK</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>With increasing number of clinical trials relating to fecal microbiota transplantation (FMT), it is crucial to identify and recruit long-term, healthy, and regular fecal donors.&lt;h4>Objective&lt;/h4>We aimed to report the outcomes of screening and recruitment of fecal donors for FMT.&lt;h4>Methods&lt;/h4>Potential donors were recruited via advertisement through internal mass emails at a university. They were required to undergo a pre-screening telephone interview, a detailed questionnaire, followed by blood and stool investigations.&lt;h4>Results&lt;/h4>From January 2017 to December 2020, 119 potential donors were assessed with 75 failed pre-screening. Reasons for failure included: inability to come back for regular and long-term donation (n = 19), high body mass index (n = 17), underly</pubmed_abstract><journal>United European gastroenterology journal</journal><pagination>1027-1038</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8598959</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>High prevalence of extended-spectrum beta-lactamase organisms and the COVID-19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong.</pubmed_title><pmcid>PMC8598959</pmcid><pubmed_authors>Chan KSP</pubmed_authors><pubmed_authors>Lau HSL</pubmed_authors><pubmed_authors>Mak WYJ</pubmed_authors><pubmed_authors>Cheung CYK</pubmed_authors><pubmed_authors>Ching YLJ</pubmed_authors><pubmed_authors>Chin ML</pubmed_authors><pubmed_authors>Lui NSR</pubmed_authors><pubmed_authors>Ng WYR</pubmed_authors><pubmed_authors>Li YLA</pubmed_authors><pubmed_authors>Chan KLF</pubmed_authors><pubmed_authors>Ng SC</pubmed_authors><pubmed_authors>Yau YK</pubmed_authors></additional><is_claimable>false</is_claimable><name>High prevalence of extended-spectrum beta-lactamase organisms and the COVID-19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong.</name><description>&lt;h4>Background&lt;/h4>With increasing number of clinical trials relating to fecal microbiota transplantation (FMT), it is crucial to identify and recruit long-term, healthy, and regular fecal donors.&lt;h4>Objective&lt;/h4>We aimed to report the outcomes of screening and recruitment of fecal donors for FMT.&lt;h4>Methods&lt;/h4>Potential donors were recruited via advertisement through internal mass emails at a university. They were required to undergo a pre-screening telephone interview, a detailed questionnaire, followed by blood and stool investigations.&lt;h4>Results&lt;/h4>From January 2017 to December 2020, 119 potential donors were assessed with 75 failed pre-screening. Reasons for failure included: inability to come back for regular and long-term donation (n = 19), high body mass index (n = 17), underly</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2025-04-04T12:15:13.773Z</modification><creation>2022-02-11T14:49:13.502Z</creation></dates><accession>S-EPMC8598959</accession><cross_references><pubmed>34623758</pubmed><doi>10.1002/ueg2.12160</doi></cross_references></HashMap>